BMS is steadily building a position in IBD through drugs like oral S1P receptor modulator Zeposia ... for patients with aggressive blood cancer acute lymphoblastic leukaemia (ALL).

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and where cancer metastasizes. A new randomized controlled trial out of ...

Orally-active S1P agonist Zeposia (ozanimod) has been submitted to the FDA as a treatment for adults with moderately to severely active ulcerative colitis (UC), with a decision from the US ...

To keep up to date with the latest Number 1s each week, sign up to our newsletter. Unsubscribe at any time.

Optic Neuritis: Clinical Features Optic neuritis refers to inflammation of the optic nerve. The term may be used broadly in reference to many causes of optic nerve inflammation including systemic ...

Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.

Cuffing season has begun! Venus’ entrance to Capricorn solidifies a love affair. This paramour is exactly who they claim to be. You may be looking for a love to last you through the winter, but ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. The mevalonate pathway produces essential ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.